Related Experiment Video
Updated: Dec 6, 2025

Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases
Published on: December 6, 2016
[COVID-19-related Cerebrovascular Disease and Vasculitis]
1Department of Stroke Medicine, Kawasaki Medical School.
Insights
Coronavirus disease 2019 (COVID-19) can cause cerebrovascular disease and vasculitis. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may infect vascular cells, leading to inflammation and critical conditions.
Area of Science:
- Neurology
- Immunology
- Infectious Diseases
Background:
- Systemic complications of COVID-19 include cerebrovascular disease and vasculitis.
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is implicated.
- Vascular endothelial cell infection via angiotensin-converting enzyme 2 (ACE2) is a proposed mechanism.
Purpose of the Study:
- To explore the link between COVID-19 and cerebrovascular/vasculitis complications.
- To understand the underlying pathophysiological mechanisms.
- To identify potential therapeutic strategies.
Main Methods:
- Review of existing literature on COVID-19-related neurological and vascular complications.
- Analysis of proposed mechanisms including viral entry via ACE2 and inflammatory pathways.
- Correlation of cerebrovascular disease and vasculitis with severe COVID-19 systemic conditions.
Main Results:
- COVID-19 is associated with increased risks of cerebrovascular disease and vasculitis.
- SARS-CoV-2 infection of vascular endothelial cells is a key proposed mechanism.
- Cytokine storm and thrombotic tendencies are linked to these complications.
Conclusions:
- COVID-19 poses significant risks for cerebrovascular and vasculitis-related diseases.
- Understanding the diverse pathophysiology is crucial for effective treatment.
- Further research is needed to establish optimal therapeutic regimens for favorable outcomes.
Abstract:
Cerebrovascular disease and vasculitis-related diseases have been reported as systemic complications of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A proposed underlying mechanism is that SARS-CoV-2 infects vascular endothelial cells via the angiotensin-converting enzyme 2 (ACE2) and causes inflammation. Cerebrovascular disease and vasculitis are often observed in severe COVID-19 cases, and they may be associated with critical systemic conditions, such as the cytokine storm and thrombotic tendencies. Several other mechanisms have been proposed, and diverse pathological conditions may be associated with COVID-19-related cerebrovascular disease and vasculitis. Clarifying the pathophysiology and establishing a better therapeutic regimen will facilitate favorable outcomes.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Vascular Spasm
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Arteries of the Head and Neck
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...

